Clinical Trial Update: Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D). [NA]

View source ↗

Summary

CoPA-D is a completed clinical trial evaluating the effect of albumin on coagulation parameters in patients with Decompensated cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis

Drugs mentioned

• Albumin

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Decompensated Cirrhosis | NA | Status: COMPLETED